Guangzhou MiLaMi E-commerce Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Guangzhou MiLaMi E-commerce Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ZILAIMI. The owner is based in Baiyun Dist, Guangzhou.

Room 314, No. 133, Jingxi Road,

Baiyun Dist, Guangzhou 510000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ZILAIMI
ZILAIMI
Registered 2024

Trademark Classifications

Guangzhou MiLaMi E-commerce Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Guangzhou MiLaMi E-commerce Trading Co., Ltd. have?

Guangzhou MiLaMi E-commerce Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guangzhou MiLaMi E-commerce Trading Co., Ltd. file in?

Guangzhou MiLaMi E-commerce Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Guangzhou MiLaMi E-commerce Trading Co., Ltd.'s most well-known trademarks?

Guangzhou MiLaMi E-commerce Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as ZILAIMI. These are among 1 currently registered trademark in the portfolio.

What is Guangzhou MiLaMi E-commerce Trading Co., Ltd.'s trademark registration success rate?

Guangzhou MiLaMi E-commerce Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.